uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer
Show others and affiliations
2005 (English)In: Cancer Research, ISSN 0008-5472, E-ISSN 1538-7445, Vol. 65, no 14, 6139-6150 p.Article in journal (Refereed) Published
Abstract [en]

The progression of several cancers is correlated with the increased synthesis of the glycosaminoglycan, hyaluronan. Hyaluronan is synthesized at the plasma membrane by various isoforms of hyaluronan synthases (HAS). The importance of HAS2 expression in highly invasive breast cancer was characterized by the antisense inhibition of HAS2 (ASHAS2). The effect of HAS2 inhibition on cell proliferation, migration, hyaluronan metabolism, and receptor status was characterized in vitro, whereas the effect on tumorigenicity and metastasis was established in vivo. HAS2 inhibition resulted in a 24-hour lag in proliferation that was concomitant to transient arrest of 79% of the cell population in G0-G1. Inhibition of HAS2 did not alter the expression of the other HAS isoforms, whereas hyaluronidase (HYAL2) and the hyaluronan receptor, CD44, were significantly down-regulated. ASHAS2 cells accumulated greater amounts of high molecular weight hyaluronan (>10,000 kDa) in the culture medium, whereas mock and parental cells liberated less hyaluronan of three distinct molecular weights (100, 400, and 3,000 kDa). The inhibition of HAS2 in the highly invasive MDA-MB-231 breast cancer cell line inhibited the initiation and progression of primary and secondary tumor formation following s.c. and intracardiac inoculation into nude mice, whereas controls readily established both primary and secondary tumors. The lack of primary and secondary tumor formation was manifested by increased survival times where ASHAS2 animals survived 172% longer than the control animals. Collectively, these unique results strongly implicate the central role of HAS2 in the initiation and progression of breast cancer, potentially highlighting the co-dependency between HAS2, CD44, and HYAL2 expression.

Place, publisher, year, edition, pages
2005. Vol. 65, no 14, 6139-6150 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-74149DOI: 10.1158/0008-5472.CAN-04-1622PubMedID: 16024615OAI: oai:DiVA.org:uu-74149DiVA: diva2:102059
Available from: 2007-01-25 Created: 2007-01-25 Last updated: 2011-02-28Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Heldin, Paraskevi
By organisation
Department of Medical Biochemistry and MicrobiologyLudwig Institute for Cancer Research
In the same journal
Cancer Research
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 126 hits
ReferencesLink to record
Permanent link

Direct link